Medication info
Pizet Tablet 2/10 mg

Pizet Tablet 2/10 mg

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 202301670 · Approved 2023.05.25 · Insurance code 645907440

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Because an initial dose of 1 milligram of pitavastatin calcium is recommended for patients with hepatic impairment, this medicine (a combination of pitavastatin calcium/ezetimibe) is not recommended for initial treatment. The maximum dose is 2/10mg daily. Use of this medicine (a combination of pitavastatin calcium/ezetimibe) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (a combination of pitavastatin calcium/ezetimibe) to patients with severe hepatic impairment.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL-cholesterol
View approved original text

This drug is used to improve cholesterol and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It specifically helps lower total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL-cholesterol levels while increasing HDL-cholesterol levels known as good cholesterol, thereby aiding in the balance of blood lipids. This medication is effective for improving blood lipids when used along with dietary therapy. Consequently, it contributes to reducing the risk of cardiovascular diseases and maintaining health. Therefore, this drug is useful for the treatment of dyslipidemia.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the reduction in LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Because an initial dose of 1 milligram of pitavastatin calcium is recommended for patients with hepatic impairment, this medicine (a combination of pitavastatin calcium/ezetimibe) is not recommended for initial treatment. The maximum dose is 2/10mg daily. Use of this medicine (a combination of pitavastatin calcium/ezetimibe) is not recommended in patients with moderate hepatic impairment. Do not administer this medicine (a combination of pitavastatin calcium/ezetimibe) to patients with severe hepatic impairment.

Precautions

This drug should not be used in patients who have a known allergy or hypersensitivity to any of its components. Patients with severe liver dysfunction or active liver disease, and patients with persistently elevated liver enzyme levels of unknown cause should also refrain from using this drug. Patients with bile duct obstruction or cholestasis, as well as those receiving cyclosporine, should not be treated with this drug. This medication is also not recommended for patients with myopathy, pregnant women or women who may become pregnant, nursing mothers, and children. Patients with lactose intolerance or related genetic disorders should not take this medication. Patients with mild liver dysfunction or who consume excessive alcohol, patients with renal dysfunction, and those using certain lipid-lowering agents should use this medication cautiously. Elderly patients, patients with hypothyroidism, patients with genetic muscular diseases or a history of muscle issues should also exercise caution. This drug may cause adverse reactions such as myalgia, weakness, or increased liver enzyme levels, so if these symptoms occur, consultation with a doctor should be sought immediately. Additionally, this drug requires regular liver function tests, and administration may be discontinued if liver dysfunction is detected. If symptoms of muscle pain or weakness appear, treatment should be ceased immediately and healthcare providers should be informed, as severe cases can lead to a serious muscle damage condition called rhabdomyolysis. This medication may interact with other drugs, so if other medications are being taken, please inform healthcare providers. Particularly with co-administration of cyclosporine, fibrate medications, or niacin, there is an increased risk of renal function deterioration and muscle damage, thus caution should be exercised. Pregnant women or nursing mothers should not use this medication, and those planning a pregnancy should ensure to consult before taking this drug. It should not be used in children as its safety and efficacy have not been established. In case of overdose, there is no specific antidote, so appropriate treatment and supportive care should be administered based on symptoms, and monitoring of liver function and muscle enzyme levels should be conducted. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Abdominal pain
  • diarrhea
  • dry mouth
  • bloating
  • gastroesophageal reflux disease
  • toothache
  • increased serum creatine phosphokinase
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weakness
Show 106 more
  • chest discomfort
  • fatigue
  • myalgia
  • dysgeusia
  • headache
  • rash
  • dizziness
  • appetite loss
  • insomnia
  • dyspnea
  • constipation
  • dryness
  • eruption
  • pruritus
  • lethargy
  • paralysis
  • thrombocytopenia
  • elevated bilirubin
  • increased cholinesterase
  • elevated gamma-glutamyl transferase
  • elevated alkaline phosphatase
  • elevated lactate dehydrogenase
  • rigidity
  • drowsiness
  • xerostomia
  • dyspepsia
  • abdominal distension
  • stomatitis
  • vomiting
  • anorexia
  • glossitis
  • nausea
  • gastric discomfort
  • thrombocytopenia
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • polyuria
  • increased BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • elevated adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • elevated myoglobin
  • palpitations
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid
  • increased serum potassium and phosphorus
  • dark urine
  • hair loss
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes mellitus
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial edema
  • arm edema
  • hypersensitivity
  • paresthesia
  • hypertension
  • chest discomfort
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • cough
  • arthralgia
  • lumbago
  • dizziness
  • limb pain
  • upper abdominal pain
  • xerostomia
  • epigastric discomfort
  • belching
  • gastrointestinal disorders
  • gastroesophageal reflux disease
  • tongue disorders
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • tremors
  • anemia
  • splenomegaly
  • conjunctival injection
  • renal failure
  • abnormal liver function
  • increased blood creatinine
  • increased blood urea nitrogen
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in an opaque container that prevents light exposure. Additionally, it is safest to store it at room temperature between 1°C and 30°C. Proper storage will help maintain the drug's effectiveness for a longer duration.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.